Identification of MXRA5 as a novel biomarker in colorectal cancer

By                

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 544-548

Spandidos Publications

Access to resources Recommend Favorite

Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer

By              

Experimental and Therapeutic Medicine, Vol. 2, Iss. 1, 2011-01 ,pp. : 73-79

Spandidos Publications

Access to resources Recommend Favorite

A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model

By                

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1412-1420

Spandidos Publications

Access to resources Recommend Favorite

Recombinant Salmonella-based CEACAM6 and 4-1BBL vaccine enhances T-cell immunity and inhibits the development of colorectal cancer in rats: In vivo effects of vaccine containing 4-1BBL and CEACAM6

By                  

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2837-2844

Spandidos Publications

Access to resources Recommend Favorite